Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, $0.0001 par value per share
-
Shares outstanding
-
84,787,696
-
Total 13F shares
-
200,884
-
Share change
-
+159,646
-
Total reported value
-
$230,191
-
Price per share
-
$1.15
-
Number of holders
-
11
-
Value change
-
+$180,602
-
Number of buys
-
7
-
Number of sells
-
2
Institutional Holders of CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) as of Q4 2024
As of 31 Dec 2024,
CITIUS ONCOLOGY, INC. - Common Shares, $0.0001 par value per share (CTOR) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
200,884 shares.
The largest 10 holders included
HRT FINANCIAL LP, UBS Group AG, CITADEL ADVISORS LLC, IFP Advisors, Inc, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, Yakira Capital Management, Inc., RENAISSANCE TECHNOLOGIES LLC, OSAIC HOLDINGS, INC., and BANK OF AMERICA CORP /DE/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.